This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter, to join the Board, effective September 20, 2022. Mr. Schechter is the President,…
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2022. “We are living in a dynamic time with a sustained global pandemic, labor shortage, supply…
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time. The company plans…
DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. This call follows this week’s U.S. Supreme…
Companies join forces to accelerate kidney care device innovation and improve patient outcomes DUBLIN and DENVER, May 26, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA)…